Stroke is the third leading cause of death in the US, primarily affecting the elderly. Nearly 15% of all strokes are related to atrial fibrillation, a relatively common arrhythmia. Antithrombotic agents (aspirin, warfarin) are used in the prevention of stroke-associated atrial fibrillation; however, they are often underutilized. The expanded use of antithrombotic agents could reduce the number of atrial fibrillation-related strokes by half. The use of warfarin demands an ability to follow instructions closely. A systematic approach to anticoagulation management has been shown to improve clinical outcomes.
The link below contains information on anticoagulation management. The ultimate goal of anticoagulation management is to reduce the disease burden associated with stroke-related atrial fibrillation and other thromboembolic conditions.